Standout Papers

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis 2011 2026 2016 2021 424
  1. BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis (2011)
    Talmadge E. King, Kevin M. Brown et al. American Journal of Respiratory and Critical Care Medicine

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 76 standout
Sub-graph 1 of 16

Citing Papers

SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys
2024 StandoutScience
Carbon-to-nitrogen single-atom transmutation of azaarenes
2023 StandoutNature
2 intermediate papers

Works of A. Morganti being referenced

Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
2013
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
2011 Standout

Author Peers

Author Last Decade Papers Cites
A. Morganti 1596 600 392 500 22 2.4k
Ari Zaiman 1840 1033 583 175 37 3.4k
Gilles Garcia 1702 930 88 140 22 2.1k
Thomas B. Crotty 1349 384 369 550 64 3.7k
Heiko Golpon 2337 1089 118 403 61 3.7k
David Lagares 750 188 368 323 35 3.2k
Diane Proudfoot 679 557 457 266 39 4.7k
Michael E. Yeager 1670 667 59 297 38 2.6k
Leopold Balleisen 742 309 278 162 41 2.1k
Dermot S. O’Callaghan 1379 750 81 233 41 2.0k
Vera Eremina 787 317 297 496 24 4.8k

All Works

Loading papers...

Rankless by CCL
2026